Menopause Flashcards

1
Q

What non hormonal treatments are available for osteoporosis?

A

Vit D supps for those at risk of low sunlight exposure
Bisphosphonates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the MOA of bisphosphonates?

A

inhibits osteoclast activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the definition of premature ovarian insufficiency?

A

Criteria - rule of 4s
- Oligo/amenorrhoea for 4 months
- FSH >25 iU/L on 2 occasions more than 4 weeks apart
- age <40 y/o

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the incidence of POI/POF?

A

1:100 (by age 40)
1:250 by age 35

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Categorise the causes of POI into 5 groups

A

genetic
immunologic
infection
metabolic
iatrogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List 4 genetic causes of POI? can be broad

A

X monosomy
X trisomy
Deletions
Translocations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List 5 immunologic causes of POI/POF

A

Hypothyroid
Addisons
Diabetic
Coeliac
APS 1 and 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Give 3 examples of infection associated with POI

A

Mumps
TB
Malaria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Give 2 examples of metabolic problems that cause POI/POF

A

17 Hydroxylase deficiency
Galactosaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Give 3 examples of iatrogenic cause of POI/POF

A

ovarian surgery
chemotherapy
radiotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

list the 5 cornerstones of POI treatment

A

MHT is the most effective treatment for alleviating VMS
Body identical hormones should be used where possible
Contraception should be discussed
Transdermal therapy should be chosen where possible
WHI data does not apply for tx of POI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the fertility options with POI

A

ovulation occurs in 25% of cases
1-10% of cases will have spontaneous pregnancy
no evidence for ovulation induction
oocyte donation has a 50% pregnancy rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the maternal mortality rate for someone with Turners syndrome

A

3%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the association between cognition and age at menopause

A

early age at surgical menopause is associated with a faster decline in cognitive function
associated with increased Alzheimer’s pathology (neuritic plaques)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the risk factors that add to the fracture risk for patients who have POI?

A

T1DM
Low BMI
Fam h/o fracture
smoking
ETOH abuse
sedentary lifestyle
Rheumatoid arthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are three autoimmune conditions associated with POI?

A

AI thyroid disease (15-20%)
Diabetes (3%) Addisons (3%) Polyglandular syndromes (3%)

17
Q

What regimen of MHT would you give to reproductive age woman with POI?

A

2mg estradiol orally
50microgram estradiol transdermally
+ progesterone

18
Q

What is the incidence of symptomatic menopause that causes diminished quality of life?

A

60%

19
Q

List 3 tools for diagnosis of osteoporosis

A
  • fracture histroy
  • DXA bone densitometry
  • FRAX score
20
Q

list 5 relative contraindications to MHT

A

H/o breast or endometrial cancer
undiagnosed vaginal bleeding
h/o CHD or VTE
active liver disease
untreated HTN

21
Q

Is family history of breast cancer a contraindication to MHT?

A

No

22
Q

List 2 breast cancer associated relative contraindication to MHT

A
  • breast cancer survivors
  • women with BRCA mutation without risk reducing surgery
23
Q

A woman presents wanting MHT but concerned about breast cancer risk, what can you advise her?

A
  • use of estrogen + progesterone in the use of women with an intact uterus is associated with an increased risk of breast cancer RR 1.2 but no chance in mortality
  • use of estrogen alone in a woman following hysterectomy associated with a lower risk of breast cancer HR 0.78 and a lower risk of breast cancer mortality HR 0.6